Jacques Jolivet

First-Line Nivolumab Plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer (CheckMate 568): Outcomes by Programmed Death Ligand 1 and Tumor Mutational Burden as Biomarkers

Neal Ready, Matthew D. Hellmann, Mark M. Awad et al. · Journal of Clinical Oncology · 2019 · 596 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

Enhanced inhibition of thymidylate synthase by methotrexate polyglutamates.

Carmen J. Allegra, Bruce A. Chabner, J C Drake et al. · Journal of Biological Chemistry · 1985 · 333 citations · Full text

Life Sciences, Biochemistry, Pharmacology +15

Inhibition of phosphoribosylaminoimidazolecarboxamide transformylase by methotrexate and dihydrofolic acid polyglutamates.

Carmen J. Allegra, J C Drake, Jacques Jolivet et al. · Proceedings of the National Academy of Sciences · 1985 · 313 citations · Full text

Medicine, Oncology, Pharmacology +7

Synthesis, Retention, and Biological Activity of Methotrexate Polyglutamates in Cultured Human Breast Cancer Cells

Jacques Jolivet, Richard L. Schilsky, Brenda D. Bailey et al. · Journal of Clinical Investigation · 1982 · 185 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +16

Unstable Methotrexate Resistance in Human Small-Cell Carcinoma Associated with Double Minute Chromosomes

Gregory A. Curt, Desmond N. Carney, Kenneth H. Cowan et al. · New England Journal of Medicine · 1983 · 179 citations

Medicine, Genetics, Oncology +17